<p>p70S6K Promotes Acquired Resistance of Erlotinib Through Induction of Epithelial-Mesenchymal Transition in Non-Small Cell Lung Carcinoma</p>
Min Li(Nanjing Medical University), Xuerong Wang(Nanjing Medical University)
Cited by 6
Related Papers
Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation
|Cancer Research|2008|159
<scp>AEG</scp>‐1 induces gastric cancer metastasis by upregulation of <scp>eIF</scp>4E expression
|Journal of Cellular and Molecular Medicine|2017|27
Trichostatin A downregulates bromodomain and extra-terminal proteins to suppress osimertinib resistant non-small cell lung carcinoma
|Cancer Cell International|2021|15
BET inhibitors combined with chemotherapy synergistically inhibit the growth of NSCLC cells
|Oncology Reports|2021|13